• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

BRD4通过调控ESPL1 mRNA的m⁶A修饰以及与ALKBH5的相互作用来调节乳腺癌进展。

BRD4 regulates mA of ESPL1 mRNA interaction with ALKBH5 to modulate breast cancer progression.

作者信息

Zhang Haisheng, Lu Linlin, Yi Cheng, Jiang Tao, Lu Yunqing, Yang Xianyuan, Zhong Ke, Zhou Jiawang, Li Jiexin, Xie Guoyou, Chen Zhuojia, Jiang Zongpei, Asadikaram Gholamreza, Peng Yanxi, Zhou Dan, Wang Hongsheng

机构信息

Guangdong Provincial Key Laboratory of Chiral Molecule and Drug Discovery; State Key Laboratory of Anti-Infective Drug Discovery and Development; School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.

Institute of Medical Sciences, the Second Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250033, China.

出版信息

Acta Pharm Sin B. 2025 Mar;15(3):1552-1570. doi: 10.1016/j.apsb.2024.12.037. Epub 2025 Jan 3.

DOI:10.1016/j.apsb.2024.12.037
PMID:40370540
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12069253/
Abstract

The interaction between mA-methylated RNA and chromatin modification remains largely unknown. We found that targeted inhibition of bromodomain-containing protein 4 (BRD4) by siRNA or its inhibitor (JQ1) significantly decreases mRNA mA levels and suppresses the malignancy of breast cancer (BC) cells increased expression of demethylase AlkB homolog 5 (ALKBH5). Mechanistically, inhibition of BRD4 increases the mRNA stability of ALKBH5 enhanced binding between its 3' untranslated regions (3'UTRs) with RNA-binding protein RALY. Further, BRD4 serves as a scaffold for ubiquitin enzymes tripartite motif containing-21 (TRIM21) and ALKBH5, resulting in the ubiquitination and degradation of ALKBH5 protein. JQ1-increased ALKBH5 then demethylates mRNA of extra spindle pole bodies like 1 (ESPL1) and reduces binding between mRNA and mA reader insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3), leading to decay of mRNA. Animal and clinical studies confirm a critical role of BRD4/ALKBH5/ESPL1 pathway in BC progression. Further, our study sheds light on the crosstalks between histone modification and RNA methylation.

摘要

N⁶-甲基化RNA与染色质修饰之间的相互作用在很大程度上仍不清楚。我们发现,通过小干扰RNA(siRNA)或其抑制剂(JQ1)靶向抑制含溴结构域蛋白4(BRD4)可显著降低mRNA的m⁶A水平,并抑制乳腺癌(BC)细胞的恶性程度,这与去甲基化酶AlkB同源物5(ALKBH5)表达增加有关。从机制上讲,抑制BRD4可增加ALKBH5的mRNA稳定性,这是通过增强其3'非翻译区(3'UTR)与RNA结合蛋白RALY之间的结合来实现的。此外,BRD4作为泛素酶含三联体基序蛋白21(TRIM21)和ALKBH5的支架,导致ALKBH5蛋白的泛素化和降解。JQ1增加的ALKBH5随后使额外纺锤极体样蛋白1(ESPL1)的mRNA去甲基化,并减少mRNA与m⁶A阅读蛋白胰岛素样生长因子2 mRNA结合蛋白3(IGF2BP3)之间的结合,导致mRNA降解。动物和临床研究证实了BRD4/ALKBH5/ESPL1通路在BC进展中的关键作用。此外,我们的研究揭示了组蛋白修饰与RNA甲基化之间的相互作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/02cc444c6d95/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/bf86d0e10e50/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/d1be9bf28f3a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/e35361509ebe/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/95aa44dd6465/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/147d84ba50d0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/fe6c38576cee/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/40bd26792966/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/02cc444c6d95/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/bf86d0e10e50/ga1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/d1be9bf28f3a/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/e35361509ebe/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/95aa44dd6465/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/147d84ba50d0/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/fe6c38576cee/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/40bd26792966/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/43f5/12069253/02cc444c6d95/gr7.jpg

相似文献

1
BRD4 regulates mA of ESPL1 mRNA interaction with ALKBH5 to modulate breast cancer progression.BRD4通过调控ESPL1 mRNA的m⁶A修饰以及与ALKBH5的相互作用来调节乳腺癌进展。
Acta Pharm Sin B. 2025 Mar;15(3):1552-1570. doi: 10.1016/j.apsb.2024.12.037. Epub 2025 Jan 3.
2
METTL3 and ALKBH5 oppositely regulate mA modification of mRNA, which dictates the fate of hypoxia/reoxygenation-treated cardiomyocytes.METTL3 和 ALKBH5 对 mRNA 的 mA 修饰起相反调控作用,从而决定了低氧/复氧处理的心肌细胞的命运。
Autophagy. 2019 Aug;15(8):1419-1437. doi: 10.1080/15548627.2019.1586246. Epub 2019 Mar 17.
3
M6A RNA Methylation Regulates Histone Ubiquitination to Support Cancer Growth and Progression.m6A RNA 甲基化调控组蛋白泛素化以支持肿瘤生长和进展。
Cancer Res. 2022 May 16;82(10):1872-1889. doi: 10.1158/0008-5472.CAN-21-2106.
4
Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.DNA 高甲基化的 ALKBH5 抑制 m6A mRNA 修饰加重 KRAS 突变/LKB1 缺失肺癌的致癌行为。
Cell Death Dis. 2021 May 20;12(6):518. doi: 10.1038/s41419-021-03793-7.
5
ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.ALKBH5 通过 m6A-YTHDF2 依赖的方式调节 STAT3 活性,影响骨肉瘤的增殖和致瘤性。
EBioMedicine. 2022 Jun;80:104019. doi: 10.1016/j.ebiom.2022.104019. Epub 2022 Apr 28.
6
ALKBH5-Mediated mA Modification of XBP1 Facilitates NSCLC Progression Through the IL-6-JAK-STAT3 Pathway.ALKBH5介导的XBP1的m⁶A修饰通过IL-6-JAK-STAT3途径促进非小细胞肺癌进展。
Mol Carcinog. 2025 Jan;64(1):57-71. doi: 10.1002/mc.23826. Epub 2024 Oct 10.
7
ALKBH5 controlled autophagy of peripheral blood mononuclear cells by regulating NRG1 mRNA stability in ankylosing spondylitis.在强直性脊柱炎中,ALKBH5通过调节NRG1 mRNA稳定性来控制外周血单个核细胞的自噬。
Int Immunopharmacol. 2025 Jan 10;144:113670. doi: 10.1016/j.intimp.2024.113670. Epub 2024 Nov 24.
8
N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.N6-甲基腺嘌呤去甲基酶 ALKBH5 通过降低 PHF20 mRNA 甲基化来抑制结直肠癌细胞的进展。
Clin Transl Med. 2022 Aug;12(8):e940. doi: 10.1002/ctm2.940.
9
Demethylase ALKBH5 suppresses invasion of gastric cancer via PKMYT1 m6A modification.去甲基酶 ALKBH5 通过 PKMYT1 m6A 修饰抑制胃癌的侵袭。
Mol Cancer. 2022 Feb 3;21(1):34. doi: 10.1186/s12943-022-01522-y.
10
m A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis.去甲基酶 ALKBH5 促进食管鳞状细胞癌的增殖,与预后不良相关。
Genes Cells. 2020 Aug;25(8):547-561. doi: 10.1111/gtc.12792. Epub 2020 Jul 1.

本文引用的文献

1
Detailed resume of RNA mA demethylases.RNA mA去甲基化酶的详细综述。
Acta Pharm Sin B. 2022 May;12(5):2193-2205. doi: 10.1016/j.apsb.2022.01.003. Epub 2022 Jan 11.
2
Lactylation-driven METTL3-mediated RNA mA modification promotes immunosuppression of tumor-infiltrating myeloid cells.乳糖化驱动的 METTL3 介导的 RNA mA 修饰促进肿瘤浸润髓系细胞的免疫抑制。
Mol Cell. 2022 May 5;82(9):1660-1677.e10. doi: 10.1016/j.molcel.2022.02.033. Epub 2022 Mar 22.
3
-Methyladenosine Regulates mRNA Stability and Translation Efficiency of KRT7 to Promote Breast Cancer Lung Metastasis.
甲基腺苷调控 KRT7 的 mRNA 稳定性和翻译效率,促进乳腺癌肺转移。
Cancer Res. 2021 Jun 1;81(11):2847-2860. doi: 10.1158/0008-5472.CAN-20-3779. Epub 2021 Apr 1.
4
RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2.RALYL 通过维持 TGF-β2 的 mRNA 稳定性来增加肝癌干细胞特性。
Nat Commun. 2021 Mar 9;12(1):1518. doi: 10.1038/s41467-021-21828-7.
5
miRNA-mediated loss of m6A increases nascent translation in glioblastoma.miRNA 介导的 m6A 缺失增加胶质母细胞瘤中的新生翻译。
PLoS Genet. 2021 Mar 8;17(3):e1009086. doi: 10.1371/journal.pgen.1009086. eCollection 2021 Mar.
6
Targeting Bromodomain and Extraterminal Proteins for Drug Discovery: From Current Progress to Technological Development.靶向溴结构域和末端外结构域蛋白的药物发现:从当前进展到技术发展。
J Med Chem. 2021 Mar 11;64(5):2419-2435. doi: 10.1021/acs.jmedchem.0c01487. Epub 2021 Feb 22.
7
YTHDF3 Induces the Translation of mA-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis.YTHDF3 通过诱导富含 mA 的基因转录本的翻译促进乳腺癌脑转移。
Cancer Cell. 2020 Dec 14;38(6):857-871.e7. doi: 10.1016/j.ccell.2020.10.004. Epub 2020 Oct 29.
8
Interplay of mA and H3K27 trimethylation restrains inflammation during bacterial infection.mA 和 H3K27 三甲基化的相互作用在细菌感染过程中抑制炎症反应。
Sci Adv. 2020 Aug 19;6(34):eaba0647. doi: 10.1126/sciadv.aba0647. eCollection 2020 Aug.
9
N-Methyladenosine co-transcriptionally directs the demethylation of histone H3K9me2.N6-甲基腺苷共转录指导组蛋白 H3K9me2 的去甲基化。
Nat Genet. 2020 Sep;52(9):870-877. doi: 10.1038/s41588-020-0677-3. Epub 2020 Aug 10.
10
Targeting BET bromodomain proteins in cancer: The example of lymphomas.靶向癌症中的 BET 溴结构域蛋白:以淋巴瘤为例。
Pharmacol Ther. 2020 Nov;215:107631. doi: 10.1016/j.pharmthera.2020.107631. Epub 2020 Jul 18.